|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
OLC1586343319 |
| 003 |
DE-627 |
| 005 |
20230512030206.0 |
| 007 |
tu |
| 008 |
001227s2001 xx ||||| 00| ||und c |
| 028 |
5 |
2 |
|a SW001227
|
| 035 |
|
|
|a (DE-627)OLC1586343319
|
| 035 |
|
|
|a (DE-599)GBVOLC1586343319
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 082 |
0 |
4 |
|a 610
|a 150
|
| 084 |
|
|
|a PHARM
|2 fid
|
| 084 |
|
|
|a CL 1000:
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.91
|2 bkl
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 100 |
1 |
|
|a Lesage, Mark G.
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Abuse liability of the anesthetic propofol: self-administration of propofol in rats under fixed-ratio schedules of drug delivery
|
| 264 |
|
1 |
|c 2001
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Stafford, David
|4 oth
|
| 700 |
1 |
|
|a Glowa, John R.
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Psychopharmacology
|d Berlin : Springer, 1976
|g 153(2001), 1, Seite 148
|w (DE-627)129320765
|w (DE-600)130601-7
|w (DE-576)014550989
|x 0033-3158
|7 nnns
|
| 773 |
1 |
8 |
|g volume:153
|g year:2001
|g number:1
|g pages:148
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a FID-PHARM
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-PSY
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_48
|
| 912 |
|
|
|a GBV_ILN_69
|
| 912 |
|
|
|a GBV_ILN_267
|
| 912 |
|
|
|a GBV_ILN_2002
|
| 912 |
|
|
|a GBV_ILN_2004
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 912 |
|
|
|a GBV_ILN_2021
|
| 912 |
|
|
|a GBV_ILN_2410
|
| 912 |
|
|
|a GBV_ILN_4012
|
| 912 |
|
|
|a GBV_ILN_4028
|
| 912 |
|
|
|a GBV_ILN_4035
|
| 912 |
|
|
|a GBV_ILN_4112
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 912 |
|
|
|a GBV_ILN_4277
|
| 912 |
|
|
|a GBV_ILN_4305
|
| 912 |
|
|
|a GBV_ILN_4306
|
| 936 |
r |
v |
|a CL 1000:
|
| 936 |
b |
k |
|a 44.38
|q AVZ
|
| 936 |
b |
k |
|a 44.91
|q AVZ
|
| 936 |
b |
k |
|a 44.40
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 153
|j 2001
|e 1
|h 148
|
